Superiority of the Child-Pugh Classification to Quantitative Liver Function Tests for Assessing Prognosis of Liver Cirrhosis

References

• Creutzfeldt W, Beck K. Erhebungen über Ätio-logie, Pathogenese, Therapieerfolge und Überle-benszeit an einem unausgewählten Krankengut von 560 Patienten mit Leberzirrhose. Dtsch Med Woch-enschr 1966; 91: 682–689
   PubMed Web of Science ®Google Scholar
• Orrego H, Blake J E, Blendis L M, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology 1987; 92: 208–214
   PubMed Web of Science ®Google Scholar
• D'Amico G, Morabito A, Pagliaro L, Marubini E, the Liver Study Group of 'V. Cervello' Hospital. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig Dis Sci 1986; 31: 468–475
   PubMed Web of Science ®Google Scholar
• Moreau R, Sicot C. Evaluation du prognostic a court terme des cirrhotiques admis en réanimation, à l'aide de 4 indices de gravité. Gastroenterol Clin Biol 1985; 9: 871–876
   PubMedGoogle Scholar
• Schlichting P, Christensen E, Andersen P K, Fauer-Holdt L, Juhl E, Poulsen H, Tygstrup N, the Copenhagen Study Group for Liver Diseases. Prognostic factors in cirrhosis identified by Cox's regression model. Hepatology 1983; 3: 889–895
   PubMed Web of Science ®Google Scholar
• Neuberger J, Altman D G, Christensen E, Tygstrup N, Williams R. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation 1986; 41: 713–716
   PubMed Web of Science ®Google Scholar
• Orrego H, Israel Y, Blake J E, Medline A. Assessment of prognostic factors in alcoholic liver disease: toward a global quantitative expression of severity. Hepatology 1983; 3: 896–905
   PubMed Web of Science ®Google Scholar
• Bircher J. Assessment of prognosis in advanced liver disease: to score or to measure, that's the question. Hepatology 1986; 6: 1036–1037
   PubMed Web of Science ®Google Scholar
• Schneider J F, Baker A L, Haines N W, Hatfield G, Boyer J L. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology 1980; 79: 1145–1150
   PubMed Web of Science ®Google Scholar
• Gill R A, Goodman M W, Golfus G R, Onstad G R, Bubrick M P. Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 1983; 198: 701–704
   PubMed Web of Science ®Google Scholar
• Villeneuve J P, Infante-Rivard C, Ampelas M, Pom-ier-Layrargues G, Huet P M, Marleau D. Prognostic value of the aminopyrine breath test in cirrhotic patients. Hepatology 1986; 6: 928–931
   PubMed Web of Science ®Google Scholar
• Gluud C, Henriksen J H, Nielsen G, the Copenhagen Study Group for Liver Diseases. Prognostic indicators in alcoholic cirrhotic men. Hepatology 1988; 8: 222–227
   PubMed Web of Science ®Google Scholar
• Pugh R NH, Murray-Lyon I M, Dawson J L, Pietroni M C, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646–649
   PubMed Web of Science ®Google Scholar
• Conn H O, Lieberthal M M. Assessment of mental state. The hepatic coma syndromes and lactulose, H O Conn, M M Lieberthal. The Williams & Wilkins Co., Baltimore 1979; 169–188
   Google Scholar
• Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest 1966; 18: 118–125
   Web of Science ®Google Scholar
• Bircher J, Blankart R, Halpern A, Häcki W, Laissue J, Preisig R. Criteria for assessment of functional impairment in patients with cirrhosis of the liver. Eur J Clin Invest 1973; 3: 72–85
   PubMed Web of Science ®Google Scholar
• Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21: 43–57
   PubMed Web of Science ®Google Scholar
• Kaplan E L, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Dixon W J. BMDP statistical software. University of California Press, Berkeley, Los Angeles 1981
   Google Scholar
• Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. 11. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, Breslow N E, Cox D R, Howard S V, Mantel N, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer 1976; 34: 585–612
   PubMed Web of Science ®Google Scholar
• Cox D R. Regression models and life-tables (with discussion). J R Statist Soc 1972; B34: 187–220
   Google Scholar
• Christensen E, Schlichting P, Fauerholdt L, Gluud C, Andcrsen P K, Juhl E, Poulsen H, et al. Prognostic value of Child-Turcotte Criteria in medically treated cirrhosis. Hepatology 1984; 4: 430–435
   PubMed Web of Science ®Google Scholar
• Infante-Rivard C, Esnaola S, Villeneuve J P. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 1987; 7: 660–664
   PubMed Web of Science ®Google Scholar
• Llach J, Gints P, Arroyo V, Rimola A, Titó L, Badalamenti S, Jiménez W, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastro-enterology 1988; 94: 482–487
   PubMed Web of Science ®Google Scholar
• Milani A, Marra L, Siciliano M, Rossi L. Prognostic significance of clinical and laboratory parameters in liver cirrhosis—a multivariate statistical approach. Hepatogastroenterology 1985; 32: 270–272
   PubMedGoogle Scholar
• Christensen E, Schlichting P, Andersen F K, Fauerholdt L, Schou G, Pedersen B V, Juhl E, et al. Updating prognosis and therapeutic effect evaluation in cirrhosis with Cox's multiple regression model for time-dependent variables. Scand J Gastroenterol 1986; 21: 163–174
   PubMed Web of Science ®Google Scholar
• Child C G, Turcotte J G. Surgery and portal hypertension. The liver and portal hypertension, C G Child. W.B. Saunders Co., Philadelphia 1964
   Google Scholar
• Campbell D P, Parker D E, Anagnostopoulos C E. Survival prediction in portacaval shunts. Am J Surg 1973; 126: 748–751
   PubMed Web of Science ®Google Scholar
• Turcotte J G, Lambert M J. Variceal hemorrhage, hepatic cirrhosis, and portacaval shunts. Surgery 1973; 73: 810–817
   PubMed Web of Science ®Google Scholar
• Conn H O, Resnick R H, Grace N D, Atterbury C E, Horst D, et al. Distal splenorenal shunt vs. portal-systemic shunt: current status of a controlled trial. Hepatology 1981; 1: 151–160
   PubMed Web of Science ®Google Scholar
• Conn H O. A peak at the Child-Turcotte classification. Hepatology 1981; 1: 673–676
   PubMedGoogle Scholar
• Sarin S K, Chari S, Sundaram K R, Ahuja R K, Anand B S, Broor S L. Young v adult cirrhotics: a prospective comparative analysis of the clinical profile, natural course and survival. Gut 1988; 29: 101–107
   PubMed Web of Science ®Google Scholar
• Pascal J P, Cales P, a multicenter study group. Pro-pranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987; 317: 856–861
   PubMed Web of Science ®Google Scholar
• Sauerbruch T, Weinzierl M, Köpcke W, Paumgart-Ner G. Long-term sclerotherapy of bleeding esophageal varices in patients with liver cirrhosis. Scand J Gastroenterol 1985; 20: 51–58
   PubMed Web of Science ®Google Scholar
• Albers I, Hartmann H, Creutzfeldt W. Vergleich quantitativer Leberfunktionsprüfungen zu klinischen, laborchemischen und bioptischen Befunden bei Patienten mit Lebererkrankungen. Z Gastroenterol 1988; 26: 130–136
   PubMed Web of Science ®Google Scholar